Skip to content

IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition

Investigating Different Dairy Wholefoods in Combination With Exercise on Inflammation, Immune Cell Function and Musculoskeletal Health in Overweight Adults

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07513987
Enrollment
60
Registered
2026-04-07
Start date
2026-05-01
Completion date
2027-12-31
Last updated
2026-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight (BMI > 25), Males and Females

Brief summary

The purpose of this study is to determine whether 12 weeks of exercise training combined with dairy consumption influences inflammation and immune responses in adults with overweight, compared to exercise training alone.

Detailed description

Individuals with overweight often have higher levels of inflammation, which can increase the risk of developing many health conditions. As adults with overweight represent a growing proportion of the Canadian population, research that emphasizes lifestyle interventions to help manage inflammation is warranted. Our proposed research combines both exercise and nutritional interventions along with detailed assessment of inflammation and immune responses in adults with overweight. This study aims to determine whether different dairy products can positively influence inflammation and immune function when consumed during a structured exercise training program. Exercise training is known to reduce inflammation, and these positive effects may be bolstered by nutritional strategies, particularly through the consumption of dairy products. Dairy products such as milk and Greek yogurt (GY) are widely accessible, nutrient-dense foods, that contain anti-inflammatory constituents that may reduce systemic inflammation. Indeed, the chronic consumption of dairy in adults with overweight has been shown to reduce inflammatory and increase in anti-inflammatory markers, in the absence of exercise training. Importantly, GY and milk may have differential effects on inflammation due to differences in their preparation and constitution. GY is a fermented dairy product with bacterial cultures that may influence the gut, whereas milk is fortified with vitamin D, which most GY in Canada lacks. With respect to exercise, new and (currently) unpublished work from our group has demonstrated some differences in the acute inflammatory response to a single exercise bout following milk or GY consumption. Yet, longer-term exercise training studies with nutrition interventions, particularly ones that explore different dairy products, are seldom designed with inflammation as the primary outcome. Moreover, most studies assess inflammation only using circulating markers and do not examine dynamic responses such as how immune cells themselves adapt over time. Rationale: Our study will help determine whether consuming different dairy products during a structured exercise training program influences inflammation and adaptations in immune responses in adults with overweight. Evidence exists for: 1) the role of exercise training in reducing inflammation in humans and inducing anti-inflammatory adaptions in immune cells in animal models, and 2) the effects of chronic dairy consumption on modulating inflammatory markers at rest. By comparing exercise training combined with milk consumption, exercise training with GY consumption, and exercise training with a habitually low-dairy diet, this study will assess whether the chronic consumption of different dairy products differentially modulate the effects of exercise training on comprehensive measures of inflammation and immune responses.

Interventions

DIETARY_SUPPLEMENTMilk

2 servings of 1% MF milk (1 serving = 250 mL) on non-training days and 3 servings on training days, integrated into habitual diet.

DIETARY_SUPPLEMENTGreek Yogurt

2 servings of plain or flavoured GY (1 serving = 175 g) on non-training days, and 3 servings of GY on training days, integrated into your habitual diet.

BEHAVIORALExercise training

12-week structured exercise training program. Exercise sessions will take place three times per week and will last approximately 60 minutes per session. Sessions will be conducted at York University in the Exercise Research Lab. Each session will be facilitated by a certified personal trainer and/or kinesiology student

Sponsors

York University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Between the ages of 18 and 50 years * Overweight BMI (25.0-29.9) kg/m2 * 'Overweight' body fat percentage (males: ≤30%; females: ≤42%) * Low to moderately physically active (0-2 times/week) * Habitual low dairy consumption (≤ 1 serving/day, assessed via baseline food record)

Exclusion criteria

* Peri- or postmenopausal status (female) * Dairy protein allergy or lactose intolerance * Use of vitamin D and/or calcium supplements * Any musculoskeletal, autoimmune, or inflammatory conditions * Use of medication related to a chronic condition

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory Cytokines assessed from blood samples via Elisaweek 0 and week 12e.g., Interleukin-6 (IL-6)
Body Composition determined via Bodpodweek 0 and week 12e.g., Lean mass
Bone turnover assessed from blood samples via Elisaweek 0 and week 12e.g., Procollagen type 1 N-propeptide (P1NP)

Secondary

MeasureTime frameDescription
Immune system function (ex vivo cellular leukocyte analyses) via flow cytometryweek 0 and week 12e.g., monocyte cell counts
Body Composition determined via Bodpodweek 0 and week 12Body fat mass
Muscle thickness determined by ultrasoundweek 0 and week 12Thickness and Cross-sectional area

Countries

Canada

Contacts

CONTACTAndrea Josse, PhD
ajosse@yorku.ca416-736-2100
CONTACTAli Abdul-Sater, PhD
aasater@yorku.ca
STUDY_DIRECTORNicholas Cheng, MSc

York University

PRINCIPAL_INVESTIGATORAndrea Josse, PhD

York University

PRINCIPAL_INVESTIGATORAli Abdul-Sater, PhD

York University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026